Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | ||||
| Current Assets | ||||
| Marketable Securities | 1,960 | 1,310 | 1,550 | 40 |
| Receivables | 240 | 1,180 | 230 | 260 |
| Inventories | 1,130 | 2,210 | 1,100 | 760 |
| Other current assets | -390 | -910 | -450 | -300 |
| TOTAL | $2,940 | $3,790 | $2,430 | $760 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 1,210 | 700 | 120 | 30 |
| TOTAL | $1,210 | $700 | $120 | $30 |
| Total Assets | $5,070 | $5,570 | $2,990 | $1,080 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 390 | 1,160 | 730 | 660 |
| Accrued Expenses | 180 | N/A | N/A | 570 |
| Other current liabilities | 710 | 1,110 | 320 | N/A |
| TOTAL | $1,750 | $2,560 | $1,790 | $1,780 |
| Non-Current Liabilities | ||||
| Long Term Debt | 620 | 250 | 400 | 500 |
| TOTAL | $620 | $250 | $400 | $500 |
| Total Liabilities | $2,380 | $2,810 | $2,190 | $2,280 |
| Shareholders' Equity | ||||
| Common Shares | 7 | 4 | 10 | 8 |
| Retained earnings | -17,260 | -9,710 | -4,240 | -2,450 |
| Other shareholders' equity | -117 | -204 | -60 | -88 |
| TOTAL | $2,690 | $2,760 | $790 | $-1,190 |
| Total Liabilities And Equity | $5,070 | $5,570 | $2,980 | $1,090 |